Search
Aligos Therapeutics Inc
ALGSAdd to Watchlist
4.230USD
-0.090-2.08%
Close 07-31 16:00（ET）Quotes delayed by 15 min
26.18MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-31The current institutional shareholding score of Aligos Therapeutics Inc is 5.00, ranking 132 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 52.29%, representing a quarter-over-quarter decrease of 33.43%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.62% of shares outstanding, with 13.10% decrease in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
Deep Track Capital LP
Roche Holding AG
Alyeska Investment Group, L.P.
Sio Capital Management, LLC
Woodline Partners LP
Marshall Wace LLP
Crestline Investors, Inc.
Two Sigma Investments, LP
1
2